ReviewAnnals of translational medicine2022
A narrative review of cortical visual prosthesis systems: the latest progress and significance of nanotechnology for the future.
Review in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 28 citations in OpenAlex.
- Article
- Study of a wideband high data rate implantable antenna for cortical visual prosthesis.Scientific reports · 2026Article
- Visual Neurorestoration: An Expert Review of Current Strategies for Restoring Vision in Humans.Brain sciences · 2025Review
- Deep Learning-Based Control of Electrically Evoked Activity in Human Visual Cortex.bioRxiv : the preprint server for biology · 2025Article
- Aerosol Jet Printing for Neuroprosthetic Device Development.Bioengineering (Basel, Switzerland) · 2025Review
- Review
- Conflicting Interests and New Frontiers: A Role for Virtue Ethics in Cutting Edge Brain Research with Humans.Neuroethics · 2025Article
- Tackling visual impairment: emerging avenues in ophthalmology.Frontiers in medicine · 2025Review
- Stability Study of Synthetic Diamond Using a Thermally Controlled Biological Environment: Application towards Long-Lasting Neural Prostheses.Sensors (Basel, Switzerland) · 2024Article
- Seeing the Future: A Review of Ocular Therapy.Bioengineering (Basel, Switzerland) · 2024Review
- Nanoparticle-based optical interfaces for retinal neuromodulation: a review.Frontiers in cellular neuroscience · 2024Review
- Evoking artificial speech perception through invasive brain stimulation for brain-computer interfaces: current challenges and future perspectives.Frontiers in neuroscience · 2024Review
- The mechanism of human color vision and potential implanted devices for artificial color vision.Frontiers in neuroscience · 2024Review
- Role of the NeuroCuple™ Device for the Postoperative Pain Management of Patients Undergoing Unilateral Primary Total Knee and Hip Arthroplasty: A Pilot Prospective, Randomized, Open-Label Study.Journal of clinical medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: We sought to review the latest developments in cortical visual prosthesis (CVP) systems and the significance of nanotechnology for the future. Over the past century, CVP systems have been researched and developed, resulting in various unique surgical and mechanical techniques. Research findings indicate that partial vision recovery is possible, with improvements in coarse target functions and performance in routine activities. Methods: This review discusses the architecture and physiology of the visual cortex, the neuroplasticity of the blind brain, and the history of CVP development, and also provides an update on the CVP systems currently being examined in research and clinical trials. Due to advances in nanotechnology, it is possible to make CVPs that are smaller, more efficient, and more biocompatible than ever before. Key Content and Findings: Currently, 3 CVPs have entered clinical trials, and several additional systems are undergoing preclinical reviews to determine the safety of the devices for chronic implantation. This development provides the first indication that the area of cortical vision restoration medication may be able to meaningfully benefit blind people. However, several significant technical and biological challenges need to be solved before the gap between artificial and natural eyesight can be reconciled. Rapid breakthroughs in nanotechnology have considerably increased its use in biological domains. Conclusions: This paper summarizes the recent progress of CVP in recent years and its future development direction. It is forecasted that nanotechnology can provide better technical support for the development of CVP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.